Scandinavian Cohort Study for Optimal Use of Portal Vein Embolization
Condition(s):Hepatic NeoplasmLast Updated:March 31, 2022Unknown status
Hide Studies Not Open or Pending
Condition(s):Hepatic NeoplasmLast Updated:March 31, 2022Unknown status
Condition(s):Liver Regeneration; Reversible Portal Vein EmbolizationLast Updated:January 24, 2024Completed
Condition(s):Liver Metastasis Colon CancerLast Updated:May 3, 2023Recruiting
Condition(s):Liver Resection; CancerLast Updated:November 7, 2019Completed
Condition(s):Portal Vein Embolization, Liver, HypertrophyLast Updated:December 21, 2022Completed
Condition(s):Procedure-Related Complication; Degree of Liver RegenerationLast Updated:June 17, 2008Completed
Condition(s):Liver and Intrahepatic Bile Duct CarcinomaLast Updated:April 7, 2023Recruiting
Condition(s):Liver Venous DeprivationLast Updated:July 14, 2022Recruiting
Condition(s):Liver Cancer; Liver MetastasesLast Updated:May 30, 2017Completed
Condition(s):Portal Vein Occlusion; Cholangiocarcinoma, Perihilar; Hepatocellular Carcinoma; Liver; Hypertrophy, AcuteLast Updated:June 17, 2020Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.